Bottom line
How much do XBI and GNOM overlap?
18% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 6.4% of XBI's assets and 17.7% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
XBI holds far more positions (161 vs 51), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings XBI and GNOM have in common
| Holding | % of XBI | % of GNOM | Overlap |
|---|---|---|---|
| Moderna Inc | 1.41% | 3.28% | 1.41% |
| Twist Bioscience Corp | 1.41% | 3.97% | 1.41% |
| Praxis Precision Medicines Inc | 1.29% | 4.01% | 1.29% |
| Natera Inc | 1.16% | 4.15% | 1.16% |
| Ultragenyx Pharmaceutical Inc | 1.14% | 2.25% | 1.14% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XBI
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
- Rhythm Pharmaceuticals Inc — 1.20%
- CG oncology Inc — 1.20%
- SELLAS Life Sciences Group Inc — 1.19%
- Vaxcyte Inc — 1.19%
- Dianthus Therapeutics Inc — 1.18%
- Cytokinetics Inc — 1.18%
- Scholar Rock Holding Corp — 1.16%
- Roivant Sciences Ltd — 1.16%
Only in GNOM
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
- Veracyte Inc — 3.64%
- Qiagen N.V. — 3.54%
- BioNTech SE — 3.41%
- Bio-techne Corporation — 3.41%
- 10X Genomics Inc — 3.23%
- Beam Therapeutics Inc — 3.09%
- Bnyrepos — 3.05%
- Eli Lilly And Company — 2.32%
Asset mix
| Asset type | XBI | GNOM |
|---|---|---|
| Stocks | 99.9% | 99.9% |
| Cash & short-term funds | 5.9% | — |
| Repurchase agreements | — | 3.1% |
| Equity derivatives | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | XBI | GNOM |
|---|---|---|
| US | 100.8% | 99.1% |
| HK | — | 2.0% |
| GB | — | 1.8% |
| IE | 1.2% | — |
| BM | 1.2% | — |
| NL | 1.0% | — |
| CH | 1.0% | — |
| VG | 0.5% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do XBI and GNOM overlap?
What stocks do XBI and GNOM have in common?
Should I own both XBI and GNOM?
Which holds more stocks, XBI or GNOM?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.